ArticleCureus2026
Beyond the Eye of the Tiger: A Case Report of Adult-Onset Pantothenate Kinase-Associated Neurodegeneration Mimicking Progressive Supranuclear Palsy-Parkinsonism.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive neurodegeneration with brain iron accumulation disorder that usually begins in childhood or adolescence; very late adult presentation can resemble more common atypical parkinsonian syndromes. We report a 54-year-old woman whose neurologic symptoms began insidiously at approximately 47 years of age with gait and balance impairment, retropulsive falls, micrographia, and dysarthria. Dysphagia, choking on liquids, urinary incontinence, and loss of independence evolved later. She had been labeled as having progressive supranuclear palsy (PSP)-parkinsonism and had no clear sustained response to escalating dopaminergic therapy. During the month before admission, dysphagia and microaspiration accelerated, culminating in acute hypoxic and hypercarbic respiratory failure requiring intubation. Review of outside records showed bilateral globus pallidus and putaminal hypointensity on brain magnetic resonance imaging (MRI), a distribution compatible with neurodegeneration with brain iron accumulation in the appropriate clinical context, and markedly reduced DaTscan uptake in both putamina with reduced right caudate uptake. The available MRI summary did not preserve the exact sequence used to demonstrate basal-ganglia hypointensity and did not document a definite eye-of-the-tiger sign; therefore, low signal was not treated as specific for iron in isolation. Outside molecular testing was documented as identifying pathogenic PANK2 variants, supporting the treating team's diagnosis of PKAN, although allele-level nomenclature and zygosity were not retained in the available record. Failed extubation led to tracheostomy and percutaneous endoscopic gastrostomy placement. This case illustrates a PSP-like late-adult PKAN phenotype in which chronology, careful interpretation of basal ganglia MRI abnormalities, and molecular testing redirected the diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.